glp 1 agonist eye side effects A potentially blinding condition is a very rare effect of the GLP-1 receptor semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no Doctor Explains GLP 1 Blindness

[DOI] [PubMed] [Google Scholar] 30.Buffa R., Capella C., Fontana P., Usellini L., Solcia E

Garvey WT, Batterham RL, Bhatta M, et al

I.V., Intravenous

In humans, unsaturated are more effective than saturated fatty acids [290,291]

22 This highlights the importance of continuous pharmacist involvement to assess tolerability, determine when dose adjustments or therapy changes are warranted, and guide patients through individualized management strategies

GLP-1 +3 Mar 19, 2026 7 min read A shift in what's possible for diabetes and obesity GLP-1 +5 Dec 16, 2025 40 min read Incretins are changing the narrative of chronic kidney disease GLP-1 +3 Dec 11, 2025 10 min read Bariatric surgery in a shot